About Cyclopharm

Cyclopharm (ASX:CYC) is a nuclear medicine company that develops, manufactures, and markets radiopharmaceuticals for the diagnosis and treatment of disease. The company’s flagship product is Technegas, which is a radiopharmaceutical used for functional lung ventilation imaging.

Snapshot

Public AUOwnership

1986Year founded

10Employees

New South Wales, AustraliaHead office

Loading Map...

Global footprint

Operations

All Locations

Australia

Products and/or services of Cyclopharm

Technegas: A radiopharmaceutical used for functional lung ventilation imaging.
Research and development: Cyclopharm is actively engaged in research and development, with a focus on developing new radiopharmaceuticals for the diagnosis and treatment of pulmonary diseases.

Cyclopharm executive team

Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO, MD, Company Secretary & Director
Mr. Jason SmithChief Financial Officer
Mr. Mathew FaragChief Operating Officer
Ms. Sally-Ann CorneliusHead of Sales
Ms. Niamh McAreeHead of Quality and Regulatory
Mr. Chris QuinnHead of Service
Ms. Sui Ling CheahFinancial Controller
Mr. Lynn McLauchlinGeneral Manager of Canada
Mr. Gary T. SomervilleQuality & Regulatory Manager